Daniel Ortega-Cuellar
Overview
Explore the profile of Daniel Ortega-Cuellar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aguilera-Mendez A, Figueroa-Fierros I, Ruiz-Perez X, Godinez-Hernandez D, Saavedra-Molina A, Rios-Chavez P, et al.
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201737
Numerous studies indicate that intrauterine growth restriction (IUGR) can predispose individuals to metabolic syndrome (MetS) in adulthood. Several reports have demonstrated that pharmacological concentrations of biotin have therapeutic effects on...
2.
Ortega-Cuellar D, Gonzalez-Sanchez I, Pinon-Zarate G, Cerbon M, De la Rosa V, Franco-Juarez Y, et al.
Biology (Basel)
. 2024 Jul;
13(7).
PMID: 39056663
Methods: RIN-m5F cells were cultured in 5 mM D-glucose (normal) or 30 mM D-glucose (high glucose) for 24 h. Cx30.2 siRNAs was used to downregulate Cx30.2 expression. Apoptosis was measured...
3.
Martinez-Rosas V, Navarrete-Vazquez G, Ortega-Cuellar D, Arreguin-Espinosa R, la Cruz V, Calderon-Jaimes E, et al.
Molecules
. 2024 Jun;
29(11).
PMID: 38893461
Metronidazole (MTZ) is the most common drug used against () infections; however, treatment failures and high rates of recurrence of trichomoniasis have been reported, suggesting the presence of resistance in...
4.
Gutierrez-Cardona J, Calderon-Jaimes E, Ortega-Cuellar D, Sanchez-Carrillo A, Castillo-Rodriguez R, Canseco-Avila L, et al.
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38674152
The parasite is the etiologic agent of trichomoniasis, the most common non-viral sexually transmitted disease worldwide. This infection often remains asymptomatic and is related to several health complications. The traditional...
5.
Morales-Luna L, Vazquez-Bautista M, Martinez-Rosas V, Rojas-Alarcon M, Ortega-Cuellar D, Gonzalez-Valdez A, et al.
Microorganisms
. 2024 Jan;
12(1).
PMID: 38257939
Several microaerophilic parasites such as , , and are major disease-causing organisms and are responsible for spreading infections worldwide. Despite significant progress made in understanding the metabolism and molecular biology...
6.
Hernandez-Ochoa B, Ortega-Cuellar D, Gonzalez-Valdez A, Martinez-Rosas V, Morales-Luna L, Rojas-Alarcon M, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37628871
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, affecting an estimated 500 million people worldwide, is a genetic disorder that causes human enzymopathies. Biochemical and genetic studies have identified several variants that produce different...
7.
Martinez-Rosas V, Hernandez-Ochoa B, Morales-Luna L, Ortega-Cuellar D, Gonzalez-Valdez A, Arreguin-Espinosa R, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511272
Giardiasis, which is caused by infection, is a relevant cause of morbidity and mortality worldwide. Because no vaccines are currently available to treat giardiasis, chemotherapeutic drugs are the main options...
8.
Mendoza-Torreblanca J, Cardenas-Rodriguez N, Carro-Rodriguez J, Contreras-Garcia I, Garciadiego-Cazares D, Ortega-Cuellar D, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373348
Dopamine (DA) and dopamine agonists (DA-Ag) have shown antiangiogenic potential through the vascular endothelial growth factor (VEGF) pathway. They inhibit VEGF and VEGF receptor 2 (VEGFR 2) functions through the...
9.
Hernandez-Ochoa B, Martinez-Rosas V, Morales-Luna L, Calderon-Jaimes E, Rocha-Ramirez L, Ortega-Cuellar D, et al.
Molecules
. 2022 Dec;
27(24).
PMID: 36558035
Protozoan parasites, such as and , cause the most prevalent infections in humans in developing countries and provoke significant morbidity and mortality in endemic countries. Despite its side-effects, metronidazole is...
10.
Morales-Luna L, Hernandez-Ochoa B, Martinez-Rosas V, Navarrete-Vazquez G, Ortega-Cuellar D, Rufino-Gonzalez Y, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430836
Treatments to combat giardiasis have been reported to have several drawbacks, partly due to the drug resistance and toxicity of current antiparasitic agents. These constraints have prompted many researchers to...